Hi, what are you looking for?
The S&P/TSX Venture Composite Index (INDEXTSI:JX) increased 1.85 percent on the week to close at 614.26 on Friday (November 29). Meanwhile, the S&P/TSX Composite...
Syntheia Corp. (‘Syntheia’ or the ‘Company’) (Syntheia.ai), CSE SYAI, Syntheia, a Canadian leader in conversational AI SaaS, is transforming customer service by delivering an...
Canadian rare earths company Mkango Resources (TSXV:MKA) has released its third quarter financial results, spotlighting the progress of its US-based HyProMag USA rare earth...
Within 24.51m of 486.30 g/t AgEq Silver47 Exploration Corp. (TSXV: AGA) (‘Silver47’ or the ‘Company), is pleased to announce the first results from the...
Group Eleven Resources Corp. (TSXV: ZNG) (OTC Pink: GRLVF) is pleased to announce its participation at the upcoming New Orleans Investment Conference on Saturday,...
Gunnison Copper (TSX:GCU,OTCQB:EXMGF) is shifting its development strategy for the Gunnison copper project in Arizona, US, laying out plans for a conventional open-pit and...
Australian antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA; Island or the Company) is pleased to announce progress on its ISLA-101 Phase 2a/b...
Lightning Minerals (L1M or the Company) is delighted to announce the discovery of spodumene within a lithium bearing pegmatite at the Company’s recently acquired...
Provaris Energy Ltd (ASX.PV1, Provaris, the Company) is pleased to present the notice of initial substantial holder. Click here for the full ASX Release...
Description During a fireside chat with analysts from Brookline Capital Markets, Radiopharm Theranostics’ (ASX:RAD) CEO Riccardo Canevari provided clinical and corporate updates highlighting the...
Perth, Australia (ABN Newswire) – BPH Energy Limited (ASX:BPH) provide a presentation by investee Cortical Dynamics at the Health Innovation Frontier Forum on 18th...
Ionic Rare Earths Limited (“IonicRE” or the “Company”) (ASX: IXR) wholly owned subsidiary Ionic Technologies is on track for the development of a unique...
Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need,...